<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.prmcm.2022.100051"><dct:format>application/xml</dct:format><dct:title>A Preliminary Study on Fructus Aurantii Extract Against Hepatocarcinoma via Glycolysis and PD-1/PD-L1 Pathway</dct:title><dct:creator>Xi Luo</dct:creator><dct:creator>Jia He</dct:creator><dct:creator>Yong-rui Bao</dct:creator><dct:creator>Shuai Wang</dct:creator><dct:creator>Tian-jiao Li</dct:creator><dct:creator>Jia-peng Leng</dct:creator><dct:creator>Xian-sheng Meng</dct:creator><dct:creator>Yan Zhang</dct:creator><dct:subject><rdf:Bag><rdf:li>Hepatocellular carcinoma</rdf:li><rdf:li>HepG2 cells</rdf:li><rdf:li>Gene regulation</rdf:li><rdf:li>Fructus Aurantii</rdf:li><rdf:li>Glycolysis</rdf:li><rdf:li>PD-1/PD-L1</rdf:li></rdf:Bag></dct:subject><dct:description>Pharmacological Research - Modern Chinese Medicine, Journal Pre-proof. doi:10.1016/j.prmcm.2022.100051</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Pharmacological Research - Modern Chinese Medicine</prism:publicationName><prism:copyright>&#169; 2022 Published by Elsevier B.V.</prism:copyright><dct:publisher>Elsevier B.V.</dct:publisher><prism:issn>2667-1425</prism:issn><prism:doi>10.1016/j.prmcm.2022.100051</prism:doi><prism:url>http://dx.doi.org/10.1016/j.prmcm.2022.100051</prism:url><dct:identifier>doi:10.1016/j.prmcm.2022.100051</dct:identifier><bam:articleNumber>100051</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2022-01-18T14:39:07Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#ElsevierWaived</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S5.1</dp:version-number></dp:document-properties><ja:article docsubtype="fla" version="5.6" xml:lang="en"><ja:item-info><ja:jid>PRMCM</ja:jid><ja:aid>100051</ja:aid><ce:article-number>100051</ce:article-number><ce:pii>S2667-1425(22)00012-4</ce:pii><ce:doi>10.1016/j.prmcm.2022.100051</ce:doi><ce:copyright type="unknown" year="2022"/></ja:item-info><ja:head><ce:title id="tte0002">A Preliminary Study on Fructus Aurantii Extract Against Hepatocarcinoma via Glycolysis and PD-1/PD-L1 Pathway</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2667142522000124-c5fd82740692169e29eb75c11143c9f0"><ce:given-name>Xi</ce:given-name><ce:surname>Luo</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="fn1"><ce:sup loc="post">&amp;</ce:sup></ce:cross-ref></ce:author><ce:author id="au0002" author-id="S2667142522000124-bda2d5e07cf3c4cf49de6e7138c0e0d7"><ce:given-name>Jia</ce:given-name><ce:surname>He</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="fn1"><ce:sup loc="post">&amp;</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2667142522000124-36186255658ef914388eb2c1ebb903d3"><ce:given-name>Yong-rui</ce:given-name><ce:surname>Bao</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2667142522000124-7425dee86c73e0f69f44c0cca4c4c5ad"><ce:given-name>Shuai</ce:given-name><ce:surname>Wang</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S2667142522000124-5005dce064f24a7b1a63a3ef91862d3a"><ce:given-name>Tian-jiao</ce:given-name><ce:surname>Li</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au0006" author-id="S2667142522000124-e4ea6fc0fb2998472f95fcb62bc3cfc3"><ce:given-name>Jia-peng</ce:given-name><ce:surname>Leng</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au0007" author-id="S2667142522000124-a848eac95bbecaedb8c55a612a050bf9"><ce:given-name>Xian-sheng</ce:given-name><ce:surname>Meng</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:mxsvvv@163.com">mxsvvv@163.com</ce:e-address></ce:author><ce:author id="au0008" author-id="S2667142522000124-fd83e151239e87bd8ada3150ac0d5cca"><ce:given-name>Yan</ce:given-name><ce:surname>Zhang</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0002" type="email" xlink:href="mailto:yanzhang1016@126.com">yanzhang1016@126.com</ce:e-address></ce:author><ce:affiliation id="aff0001" affiliation-id="S2667142522000124-47f79a5c090c11e9ba028cd9f3a56509"><ce:label>1</ce:label><ce:textfn id="cetextfn0001">Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, People's Republic of China.</ce:textfn><sa:affiliation><sa:organization>Liaoning University of Traditional Chinese Medicine</sa:organization><sa:city>Shenyang</sa:city><sa:postal-code>110847</sa:postal-code><sa:country>People's Republic of China</sa:country></sa:affiliation><ce:source-text id="staff0001">1Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, People's Republic of China.</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Correspondence: Prof. Xian-sheng Meng, College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, 116600, People's Republic of China. Prof. Yan Zhang, Liaoning University of Traditional Chinese Medicine, Shenyang, 110000, People's Republic of China.</ce:text><sa:affiliation><sa:organization>College of Pharmacy</sa:organization><sa:organization>Liaoning University of Traditional Chinese Medicine</sa:organization><sa:organization>Liaoning University of Traditional Chinese Medicine</sa:organization><sa:city>Dalian</sa:city><sa:postal-code>116600</sa:postal-code><sa:country>People's Republic of China</sa:country></sa:affiliation></ce:correspondence><ce:footnote id="fn1"><ce:label>&amp;</ce:label><ce:note-para id="notep0001" view="all">These authors contributed equally to this work and should be considered co-first authors.</ce:note-para></ce:footnote></ce:author-group><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">ABSTRACT</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara013" view="all">Fructus Aurantii (FA) is a traditional herbal medicine that has been widely used for thousands of years in China and possesses a variety of pharmacological effects. FA is full of flavonoids. Several natural bioactive compounds of FA are involved in the treatment of various types of cancers, however, the beneficial effects of FA in hepatocarcinoma and the potential mechanisms of its therapeutic effects have not been fully explored. The present study investigates the anticancer role of flavonoids extracted from FA on human hepatoblastoma cell, HepG2. Eriocitrin, neoeriocitrin, narirutin, naringin, hesperidin, neohesperidin, hesperitin, poncirin, meranzin, nobiletin and tangeretin were identified in FAE. The FAE inhibit the proliferation of HepG2 cells in a dose-dependent manner. Metabolic alteration was detected by cell metabolomics and quantitative real time polymerase chain reaction. Flavonoids decreased the level of glycolysis rate-limiting enzymes gene expression in HepG2 cells. It was also observed that the PD-1 and PD-L1 gene expression level were decreased in FAE-treated cells. Collectively, these results suggest that flavonoid extracted from FA inhibits HepG2 cell proliferation by glycolysis and its downstream of PD-1/PD-L1 pathway. These findings suggest that the possible mechanism by which FA exerts its activities in the treatment of hepatocarcinoma and lays a foundation for further experiments and the development of a rational clinical application of FA, which still needs further <ce:italic>in vivo</ce:italic> investigation in animals and human beings.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0002">KEYWORDS</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Hepatocellular carcinoma</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">HepG2 cells</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Gene regulation</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Fructus Aurantii</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">Glycolysis</ce:text></ce:keyword><ce:keyword id="key0006"><ce:text id="cetext0007">PD-1/PD-L1</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
